Ultragenyx Pharmaceutical Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $100.5M | $161.1M | $93.6M | $24.3M | $7.4M |
| Accounts Receivable | $5.2M | — | — | — | — |
| Inventory | $757.0K | — | — | — | — |
| Total Current Assets | $269.6M | $401.7M | $450.2M | $193.4M | $55.2M |
| Property, Plant & Equipment | $21.8M | $17.1M | $7.4M | $3.0M | $1.3M |
| Goodwill | $44.4M | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $141.5M | — | — | — | — |
| Total Assets | $490.8M | $540.6M | $559.6M | $198.0M | $59.6M |
| Liabilities | |||||
| Accounts Payable | $8.9M | $5.4M | $2.9M | $4.9M | $1.4M |
| Total Current Liabilities | $71.0M | $60.3M | $27.9M | $12.5M | $5.9M |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $107.3M | $66.7M | $28.5M | $13.0M | $9.5M |
| Stockholders' Equity | |||||
| Retained Earnings | $-832.7M | $-530.5M | $-284.7M | $-139.0M | $-74.8M |
| Total Stockholders' Equity | $383.5M | $474.0M | $531.1M | $184.9M | $-74.8M |